Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Blood norepinephrine levels during responses to the heart-lung preparation to methylguanidine.

Krayer O, Weiner N, Mosimann W.

J Pharmacol Exp Ther. 1972 Apr;181(1):108-15. No abstract available.

PMID:
5013149
2.

Rate-increasing action of methylguanidine upon the isolated mammalian heart.

Krayer O, Mosimann W, Silver G.

J Pharmacol Exp Ther. 1966 Oct;154(1):73-82. No abstract available.

PMID:
5924315
3.

STUDIES ON VERATRUM ALKALOIDS. XXXVII. CHRONOTROPIC CARDIAC ACTION AND TOXICITY OF N-ALKYL DERIVATIVES OF VERATRAMINE.

HAWKINS DF, UHLE FC, KRAYER O.

J Pharmacol Exp Ther. 1964 Sep;145:275-85. No abstract available.

PMID:
14214427
4.

PHARMACOLOGY OF RESERPINE AND ITS IMPLICATIONS FOR ANESTHESIA.

ALPER MH, FLACKE W, KRAYER O.

Anesthesiology. 1963 Jul-Aug;24:524-42. Review. No abstract available.

PMID:
14044784
5.

[On chronotropic heart effects].

KRAYER O.

Klin Wochenschr. 1963 Mar 15;41:272-6. German. No abstract available.

PMID:
14035622
6.

Action of guanethidine and reserpine upon the isolated mammalian heart.

KRAYER O, ALPER MH, PAASONEN MK.

J Pharmacol Exp Ther. 1962 Feb;135:164-73. No abstract available.

PMID:
14459487
7.

Rate-increasing action of corticotropin and of alpha-intermedin in the isolated mammalian heart.

KRAYER O, ASTWOOD EB, WAUD DR, ALPER MH.

Proc Natl Acad Sci U S A. 1961 Aug;47:1227-36. No abstract available.

8.

The history of the Bezold-Jarisch effect.

KRAYER O.

Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1961;240:361-8. No abstract available.

PMID:
13754157
9.
10.

The content of noradrenaline and adrenaline in the rat heart after administration of Rauwolfia alkaloids.

PAASONEN MK, KRAYER O.

Experientia. 1959 Feb 15;15(2):75-6. No abstract available.

PMID:
13639927
11.

Threshold dose and time course of norepinephrine depletion of the mammalian heart by reserpine.

WAUD DR, KOTTEGODA SR, KRAYER O.

J Pharmacol Exp Ther. 1958 Dec;124(4):340-6. No abstract available.

PMID:
13611637
12.
13.
14.

The release of norepinephrine from the mammalian heart by reserpine.

PAASONEN MK, KRAYER O.

J Pharmacol Exp Ther. 1958 Jun;123(2):153-60. No abstract available.

PMID:
13550070
15.

Changes of heart rate caused by direct cardiac action of reserpine.

KRAYER O, FUENTES J.

J Pharmacol Exp Ther. 1958 Jun;123(2):145-52. No abstract available.

PMID:
13550069
16.
17.

Synthetic esters of dimethylaminoethanol exhibiting positive inotropic cardiac activity.

UHLE FC, MITMAN BA, KRAYER O.

J Pharmacol Exp Ther. 1956 Apr;116(4):444-9. No abstract available.

PMID:
13320287
18.

Properties of a toxin from the salivary gland of the shrew, Blarina brevicauda.

ELLIS S, KRAYER O.

J Pharmacol Exp Ther. 1955 Jun;114(2):127-37. No abstract available.

PMID:
14392580
19.

Studies on veratrum alkaloids, XXII. Periodic activity of the sino-auricular node of the denervated cat heart caused by veratramine.

KOSTERLITZ HW, KRAYER O, MATALLANA A.

J Pharmacol Exp Ther. 1955 Apr;113(4):460-9. No abstract available.

PMID:
14368515
20.

Studies on veratrum alkaloids. XXI. The action of veratramine upon impulse generation in the dog heart.

KRAYER O, ARORA RB, MEILMAN E.

J Pharmacol Exp Ther. 1955 Apr;113(4):446-59. No abstract available.

PMID:
14368514
21.

[Rate frequency of acute denervated heart in heart-lung preparation in dog with reference to the accelerating effect of adrenaline].

KRAYER O, BENFORADO JM.

Pflugers Arch Gesamte Physiol Menschen Tiere. 1955;260(3):177-87. German. No abstract available.

PMID:
14394791
22.
23.

The effect of moderately large doses of veratramine and veratrosine on the rhythm of the acutely denervated heart of the cat.

KOSTERLITZ HW, KRAYER O, MATALLANA A.

J Physiol. 1954 May 28;124(2):40P. No abstract available.

24.

[Studies on Veratrum alkaloids. XVIII. Chemical and pharmacological relations between Zygadenus and Veratrum alkaloids].

KRAYER O, KUPCHAN SM, DELIWALA CV, ROGERS BH.

Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;219(5):371-85. Undetermined Language. No abstract available.

PMID:
13099374
25.

Clinical studies on veratrum alkaloids. II. The dose-response relations of protoveratrine in hypertension.

MEILMAN E, KRAYER O.

Circulation. 1952 Aug;6(2):212-21. No abstract available.

PMID:
14936216
26.

Antiaccelerator cardiac agents.

KRAYER O.

J Mt Sinai Hosp N Y. 1952 May-Jun;19(1):53-69. No abstract available.

PMID:
14938973
27.
28.
30.

Studies on solanum alkaloids: II. The anti-accelerator cardiac action of solasodine and some of its derivatives.

KRAYER O, BRIGGS LH.

Br J Pharmacol Chemother. 1950 Dec;5(4):517-25. No abstract available.

31.

The antiaccelerator cardiac action of quinine and quinidine.

KRAYER O.

J Pharmacol Exp Ther. 1950 Oct;100(2):146-50. No abstract available.

PMID:
14784951
32.

The effects of protoveratrine, a pure veratrum alkaloid in hypertensive patients.

MEILMAN E, KRAYER O.

J Clin Invest. 1950 Jun;29(6):833-4. No abstract available.

33.
34.

Studies on solanum alkaloids; the anti-accelerator cardiac action of beta-dihydrosolasodine and tetrahydrosolasodine.

KRAYER O, BRIGGS LH.

Br J Pharmacol Chemother. 1950 Mar;5(1):118-24. No abstract available.

35.

Clinical studies on veratrum alkaloids; the action of protoveratrine and veratridine in hypertension.

MEILMAN E, KRAYER O.

Circulation. 1950 Feb;1(2):204-13. No abstract available.

PMID:
15409589
36.

[Investigations into the effect of veratrumalkaloid on the circulation].

KRAYER O.

Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1950;209(4-5):405-20. Undetermined Language. No abstract available.

PMID:
15419656
37.
38.
39.

Studies on veratrum alkaloids; veratramine, an antagonist to the cardioaccelerator action of epinephrine.

KRAYER O.

J Pharmacol Exp Ther. 1949 Aug;96(4 Pt. 1):422-37. No abstract available.

PMID:
18137898
40.

Plasma neostigmine levels and cholinesterase inhibition in dogs and myasthenic patients.

GOLDSTEIN A, KRAYER O, et al.

J Pharmacol Exp Ther. 1949 May;96(1):56-85. No abstract available.

PMID:
18150736
41.

Veratramine, an antagonist of the cardioaccelerator action of epinephrine.

KRAYER O.

Proc Soc Exp Biol Med. 1949 Apr;70(4):631. No abstract available.

PMID:
18149451
42.

Die Kreislaufwirkung der Veratrum-Alkaloide.

KRAYER O.

Med Klin. 1949 Feb 25;44(8):248. Undetermined Language. No abstract available.

PMID:
18200722
43.

Hemmungsstoffe der Cholinesterase.

KRAYER O.

Med Klin. 1949 Feb 18;44(7):217. Undetermined Language. No abstract available.

PMID:
18225005
44.

Experimental heart failure caused by central nervous system depressants and local anesthetics.

WOLLENBERGER A, KRAYER O.

J Pharmacol Exp Ther. 1948 Dec;94(4):439-43. No abstract available.

PMID:
18105661
45.

Action of cysteine and of dimercaptopropanol in heart failure caused by sodium bismuth tartrate.

KRAYER O, FARAH A.

Fed Proc. 1948 Mar;7(1 Pt 1):235. No abstract available.

PMID:
18938552
46.

The influence of antitoxin upon the action of Clostridium oedematiens toxin in the heart-lung preparation of the dog.

KRAYER O, AUB JC, et al.

J Clin Invest. 1947 May;26(3):411-5. No abstract available.

PMID:
20257803
47.

THE INFLUENCE OF ANTITOXIN UPON THE ACTION OF CLOSTRIDIUM OEDEMATIENS TOXIN IN THE HEART-LUNG PREPARATION OF THE DOG.

Krayer O, Aub JC, Nathanson IT, Zamecnik PC.

J Clin Invest. 1947 May;26(3):411-5. No abstract available.

48.

Pharmakologische Versuche mit einigen Veratrum-Alkaloiden.

KRAYER O.

Schweiz Med Wochenschr. 1947 Mar 29;77(13):389. Undetermined Language. No abstract available.

PMID:
20296865
49.
50.

The pharmacology of the veratrum alkaloids.

KRAYER O, ACHESON GH.

Physiol Rev. 1946 Jul;26(3):383-446. No abstract available.

Supplemental Content

Loading ...
Support Center